Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

A Cost-Effective Predicting Model for Recurrent Gastric Cancer by Clinical Features

Version 1 : Received: 11 March 2024 / Approved: 14 March 2024 / Online: 15 March 2024 (10:41:57 CET)

A peer-reviewed article of this Preprint also exists.

Chen, C.-C.; Ting, W.-C.; Lee, H.-C.; Chang, C.-C.; Lin, T.-C.; Yang, S.-F. A Cost-Effective Model for Predicting Recurrent Gastric Cancer Using Clinical Features. Diagnostics 2024, 14, 842. Chen, C.-C.; Ting, W.-C.; Lee, H.-C.; Chang, C.-C.; Lin, T.-C.; Yang, S.-F. A Cost-Effective Model for Predicting Recurrent Gastric Cancer Using Clinical Features. Diagnostics 2024, 14, 842.

Abstract

This study was to identify clinical cancer biomarkers for recurrent gastric cancer survivors using artificial intel-ligence. From a hospital-based cancer registry database in Taiwan, the datasets of the incidence of recurrence and clinical risk features were included in 2476 gastric cancer survivors. We benchmarked Random forest with MLP, C4.5, AdaBoost, and Bagging algorithms on metrics and leveraged synthetic minority oversampling technique (SMOTE) for imbalanced dataset issues, cost-sensitive learning for risk assessment, and SHapley Additive ex-Planations (SHAP) for feature importance analysis in this study. Our proposed Random forest outperformed the other models with an accuracy of 87.9%, a recall rate of 90.5%, an accuracy rate of 86% and F1 of 88.2% on re-current category by a 10-fold cross-validation in a balanced dataset. We identified clinical features of recurrent gastric cancer, which are the top five features, stage, number of regional lymph node involvement, Helicobacter pylori, BMI(body mass index), and gender, which significantly affect the prediction model's output, are worth paying attention to in the following causal effect analysis. Using an artificial intelligence model, the risk factors for recurrent gastric cancer could be identified and cost-effectively ranked according to their feature importance. In addition, they should be crucial clinical features to provide physicians with the knowledge to screen high-risk patients in gastric cancer survivors as well.

Keywords

Recurrent Gastric Cancer, Random Forest, SMOTE, SHAP, Cost-Sensitive Learning

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.